.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Robotic-assisted gynecologic surgery offers articulated instruments, three-dimensional visualization and ergonomic advantages that may help surgeons perform complex minimally invasive procedures. Comparative studies have shown that robotic approaches can achieve similar perioperative outcomes to conventional laparoscopy for many benign and oncologic operations, although costs and operating time may be higher. The key lesson from gynecologic oncology is that technology should be evaluated against meaningful endpoints. The LACC experience in cervical cancer demonstrated that minimally invasive radical hysterectomy could have worse survival despite favorable perioperative features, emphasizing that surgical platform alone does not guarantee equivalent cancer control. For clinicians, robotic adoption should therefore be driven by appropriate patient selection, surgeon training, institutional expertise and evidence for the specific operation—not by the technology label itself.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Robotic-assisted gynecologic surgery offers articulated instruments, three-dimensional visualization and ergonomic advantages that may help surgeons perform complex minimally invasive procedures. Comparative studies have shown that robotic approaches can achieve similar perioperative outcomes to conventional laparoscopy for many benign and oncologic operations, although costs and operating time may be higher. The key lesson from gynecologic oncology is that technology should be evaluated against meaningful endpoints. The LACC experience in cervical cancer demonstrated that minimally invasive radical hysterectomy could have worse survival despite favorable perioperative features, emphasizing that surgical platform alone does not guarantee equivalent cancer control. For clinicians, robotic adoption should therefore be driven by appropriate patient selection, surgeon training, institutional expertise and evidence for the specific operation—not by the technology label itself.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
